A detailed history of Clean Yield Group transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clean Yield Group holds 160 shares of GILD stock, worth $14,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Holding current value
$14,785
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$66.59 - $83.99 $10,654 - $13,438
160 New
160 $13,000
Q3 2023

Oct 12, 2023

BUY
$73.94 - $80.67 $7,320 - $7,986
99 New
99 $7,000
Q4 2022

Jan 31, 2023

SELL
$62.32 - $89.47 $1,869 - $2,684
-30 Reduced 60.0%
20 $1,000
Q3 2022

Oct 31, 2022

SELL
$59.54 - $68.01 $29,770 - $34,005
-500 Reduced 90.91%
50 $3,000
Q2 2022

Jul 18, 2022

SELL
$57.72 - $65.01 $6,926 - $7,801
-120 Reduced 17.91%
550 $34,000
Q1 2022

Apr 25, 2022

SELL
$57.92 - $72.58 $868 - $1,088
-15 Reduced 2.19%
670 $40,000
Q4 2021

Jan 24, 2022

SELL
$64.88 - $73.64 $86,290 - $97,941
-1,330 Reduced 66.0%
685 $50,000
Q3 2021

Oct 27, 2021

SELL
$67.69 - $73.03 $19,630 - $21,178
-290 Reduced 12.58%
2,015 $141,000
Q2 2021

Jul 26, 2021

SELL
$63.47 - $69.35 $134,873 - $147,368
-2,125 Reduced 47.97%
2,305 $159,000
Q1 2021

Apr 26, 2021

SELL
$60.0 - $68.46 $161,580 - $184,362
-2,693 Reduced 37.81%
4,430 $286,000
Q4 2020

Jan 26, 2021

SELL
$56.65 - $64.55 $1.25 Million - $1.42 Million
-22,017 Reduced 75.56%
7,123 $415,000
Q3 2020

Oct 16, 2020

SELL
$62.1 - $78.08 $784,819 - $986,775
-12,638 Reduced 30.25%
29,140 $1.84 Million
Q2 2020

Jul 22, 2020

SELL
$72.34 - $84.0 $45,863 - $53,256
-634 Reduced 1.49%
41,778 $3.21 Million
Q1 2020

Apr 20, 2020

SELL
$62.63 - $80.22 $121,439 - $155,546
-1,939 Reduced 4.37%
42,412 $3.17 Million
Q4 2019

Jan 17, 2020

SELL
$61.62 - $67.78 $655,636 - $721,179
-10,640 Reduced 19.35%
44,351 $2.88 Million
Q3 2019

Oct 23, 2019

BUY
$62.51 - $69.0 $25,316 - $27,945
405 Added 0.74%
54,991 $3.49 Million
Q2 2019

Jul 22, 2019

BUY
$61.87 - $69.38 $4,021 - $4,509
65 Added 0.12%
54,586 $3.69 Million
Q1 2019

Apr 24, 2019

BUY
$62.53 - $70.05 $786,689 - $881,299
12,581 Added 30.0%
54,521 $3.54 Million
Q4 2018

Jan 23, 2019

SELL
$60.54 - $79.0 $185,736 - $242,372
-3,068 Reduced 6.82%
41,940 $2.62 Million
Q3 2018

Oct 22, 2018

SELL
$71.28 - $78.92 $13,400 - $14,836
-188 Reduced 0.42%
45,008 $3.48 Million
Q2 2018

Jul 24, 2018

BUY
$64.88 - $75.68 $32,699 - $38,142
504 Added 1.13%
45,196 $3.2 Million
Q1 2018

Apr 23, 2018

SELL
$72.84 - $88.8 $7,284 - $8,880
-100 Reduced 0.22%
44,692 $3.37 Million
Q4 2017

Jan 16, 2018

SELL
$71.15 - $83.52 $211,315 - $248,054
-2,970 Reduced 6.22%
44,792 $3.21 Million
Q3 2017

Oct 11, 2017

BUY
$72.11 - $85.47 $3.44 Million - $4.08 Million
47,762
47,762 $3.87 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.